Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoqin Su

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Biopharmaceutical Statistics|June 1, 2005
Sample size and power analysis for endometrial safety studiesGuoqin Su
Journal of Statistical Planning and Inference|November 4, 2009
Statistical Scoring Procedures Applicable to Laboratory Performance EvaluationA S Hedayat, Guoqin Su, W Elane Streets
Statistical Methods in Medical Research|October 31, 2018
A proof-of-concept-to-confirmatory multiple adaptation design in the development of an anti-viral treatmentXiaoyin F Fan, Paul Gallo, Guoqin Su, et al.
Malaria Journal|December 5, 2023
Estimated distribution of malaria cases among children in sub-Saharan Africa by specified age categories using data from the Global Burden of Diseases 2019Olorunfemi A Oshagbemi, Pedro Lopez-Romero, Cornelis Winnips, et al.
Therapeutic Advances in Endocrinology and Metabolism|August 25, 2015
Effect of zoledronic acid on serum calcium in Paget's disease patients after educational strategies to improve calcium and vitamin D supplementationJoseph R Tucci, Henry G Bone, Guoqin Su, et al.
Journal of the American Dental Association (1939)|November 2, 2010
The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials programJohn T Grbic, Dennis M Black, Kenneth W Lyles, et al.
Bone|March 23, 2011
Health-related quality of life and treatment of postmenopausal osteoporosis: results from the HORIZON-PFTPhilip N Sambrook, Stuart L Silverman, Jane A Cauley, et al.
Bone|November 9, 2011
Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronatePhilip N Sambrook, Christian Roux, Jean-Pierre Devogelaer, et al.
Calcified Tissue International|November 1, 2011
Subtrochanteric fractures in bisphosphonate-naive patients: results from the HORIZON-recurrent fracture trialJonathan D Adachi, Kenneth Lyles, Steven Boonen, et al.
Rheumatology (Oxford, England)|February 1, 2013
Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoidsJean-Pierre Devogelaer, Philip Sambrook, David M Reid, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Biopharmaceutical Statistics|June 1, 2005
Sample size and power analysis for endometrial safety studiesGuoqin Su
Journal of Statistical Planning and Inference|November 4, 2009
Statistical Scoring Procedures Applicable to Laboratory Performance EvaluationA S Hedayat, Guoqin Su, W Elane Streets
Statistical Methods in Medical Research|October 31, 2018
A proof-of-concept-to-confirmatory multiple adaptation design in the development of an anti-viral treatmentXiaoyin F Fan, Paul Gallo, Guoqin Su, et al.
Malaria Journal|December 5, 2023
Estimated distribution of malaria cases among children in sub-Saharan Africa by specified age categories using data from the Global Burden of Diseases 2019Olorunfemi A Oshagbemi, Pedro Lopez-Romero, Cornelis Winnips, et al.
Therapeutic Advances in Endocrinology and Metabolism|August 25, 2015
Effect of zoledronic acid on serum calcium in Paget's disease patients after educational strategies to improve calcium and vitamin D supplementationJoseph R Tucci, Henry G Bone, Guoqin Su, et al.
Journal of the American Dental Association (1939)|November 2, 2010
The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials programJohn T Grbic, Dennis M Black, Kenneth W Lyles, et al.
Bone|March 23, 2011
Health-related quality of life and treatment of postmenopausal osteoporosis: results from the HORIZON-PFTPhilip N Sambrook, Stuart L Silverman, Jane A Cauley, et al.
Bone|November 9, 2011
Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronatePhilip N Sambrook, Christian Roux, Jean-Pierre Devogelaer, et al.
Calcified Tissue International|November 1, 2011
Subtrochanteric fractures in bisphosphonate-naive patients: results from the HORIZON-recurrent fracture trialJonathan D Adachi, Kenneth Lyles, Steven Boonen, et al.
Rheumatology (Oxford, England)|February 1, 2013
Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoidsJean-Pierre Devogelaer, Philip Sambrook, David M Reid, et al.
Pageof 3